Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

Levels of a protein called aprataxin are related to patient response to irinotecan, a drug used in the chemotherapy of patients with colon cancer.

VHIR researchers have discovered how abnormal protein clusters in nerve cells are associated with neuronal death in Parkinson's disease and propose a new experimental therapeutic strategy.

The Vall d'Hebron University Hospital Research Institute demonstrates how there is a significant decrease in the secretion of inflammatory signals of the intestinal mucosa in Crohn's disease thanks to the presence of Lactobacillus casei.

The study, published today in The New England Journal of Medicine, involved researchers from Vall d'Hebron University Hospital.